Real life management of chronic urticaria: Multicenter and cross sectional study on patients and dermatologists in Iran

Firooz, A. and Akhlaghi, A. and Golbidi, P. and Pourjafari, M. and Abdollahimajd, F. and Azimi, H. and Banihashemi, M. and Darvish Damavandi, F. and Erfani, A.R. and Farajzadeh, S. and Ghassemi, M. and Gheisari, M. and Hamedpour, K. and Handjani, F. and Hashemi, S.A. and Herizchi, H. and Iraji, F. and Jalili, H. and Khatami, A. and Lajevardi, V. and Mansouri, P. and Masjedi, H. and Mehrian, P. and Mohammadi, S. and Mohebbi, A. and Namazi, N. and Nasiri Kashani, M. and Radmehr, A. and Safar, F. and Saffarian, Z. and Saneei, S. and Seirafi, H. and Taheri, S. and Yazdanpanah, M.J. and Zaboli Nejad, N. and Naseri, M. and Peiravi, P. and Teymori, G. (2019) Real life management of chronic urticaria: Multicenter and cross sectional study on patients and dermatologists in Iran. Dermatologic Therapy, 32 (2).

Full text not available from this repository.
Official URL:


Recently, advances in understanding the etiology of urticaria and updates of diagnostic and therapeutic management guidelines have drawn attention to chronic urticaria (CU) morbidity. The present study aimed to evaluate Iranian dermatologists' practice and real life management of CU patients. A total of 35 dermatologists and 443 patients were included in the study. Number of female patients was 321 (72.5). Mean (standard deviation) age of the study patients was 38 (13) years and the median (inter quartile range) of disease duration was 12 (6�48) months. Severity of patients' symptoms was mild for 32.1, moderate for 38.7, severe for 18.8, and 10.4 of them had no evident signs or symptoms. The most common diagnostic methods were physical examination (96.6), differential blood count (83.5), erythrocyte sedimentation rate (77.4), and C-reactive protein (62.8). The number of dermatologists prescribed nonsedating antihistamines (nsAH) in regular dose and high dose mono therapy were 26 (74) and 6 (17), respectively. About 66 of dermatologists were familiar with British Association of Dermatologists (BAD) guideline. The most common first-line treatment for CU by Iranian dermatologists was nonsedating antihistamines in regular or high doses. The real-life management of patients with CU in Iran was in accordance with the available practice guidelines. © 2018 Wiley Periodicals, Inc.

Item Type: Article
Additional Information: cited By 0
Subjects: WR Dermatology
Depositing User: eprints admin
Date Deposited: 27 Oct 2020 10:12
Last Modified: 27 Oct 2020 10:12

Actions (login required)

View Item View Item